Web-Assisted Qual-TDI To Aid New Product Development

1. Web-Assisted Qual-TDI To Aid New Product Development Study Type Web Assisted Qualitative TDI Sample Size Background Objective Research Methodology Outcome n=20 The client wanted to understand NeuromyelitisOptica Spectrum Disorder to aid new product development The client wanted to gather professional opinion in terms of prescriptions, current treatment options, attributes of patients and treatment areas of specific patients via patient referral forms In-depth feedback from participants regarding the number of NMOSD patients they treat, use of infusion therapy and feedback on the new product profile. Conducted in-depth telephonic interviews among neurologists who treat NMOSD, as a full service Target audience included neurologists who treat NMO/NMOSD patients Sample size was based on appropriate quota as per client instruction People with NMOSD experience unpredictable, severe relapses that directly cause cumulative, permanent, neurological damage and disability The new product promotes interleukin-6 (IL-6) signaling, which played a key role in inflammation that occurs in people with NMOSD Target Group Neurologists Business Impact Geography Using study insights, the client was able to finalize the optimal positioning elements for launch Germany, France, Spain, Italy connect@borderlessaccess.com www.borderlessaccess.com